Soluble Urokinase-Type Plasminogen Activator Receptor as a Prognostic Marker of Ugandan Children at Risk of Severe and Fatal Malaria

Veselina Stefanova, Michelle Ngai, Andrea M. Weckman, Julie K. Wright, Kathleen Zhong, Melissa Richard-Greenblatt, Chloe R. McDonald, Andrea L. Conroy, Sophie Namasopo, Robert O. Opoka, Michael Hawkes, Kevin C. Kain

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Background: Current malaria diagnostic tests do not reliably identify children at risk of severe and fatal infection. Host immune and endothelial activation contribute to malaria pathogenesis. Soluble urokinase-Type plasminogen activator receptor (suPAR) is a marker of these pathways. We hypothesized that measuring suPAR at presentation could risk-stratify children with malaria. Methods: Plasma suPAR levels were determined in consecutive febrile children with malaria at presentation to hospital in Jinja, Uganda.

Original languageEnglish (UK)
Pages (from-to)E1079-E1086
JournalClinical Infectious Diseases
Volume76
Issue number3
DOIs
Publication statusPublished - 1 Feb 2023
Externally publishedYes

Keywords

  • mortality outcome
  • prognostic marker
  • risk-stratification
  • severe malaria
  • soluble urokinase-Type plasminogen activator receptor

Fingerprint

Dive into the research topics of 'Soluble Urokinase-Type Plasminogen Activator Receptor as a Prognostic Marker of Ugandan Children at Risk of Severe and Fatal Malaria'. Together they form a unique fingerprint.

Cite this